Magnetic resonace imaging study in major psychiatric disorders

Journal of the Medical Association of Thailand

Volumn 87, Issue SUPPL. 2, 2004, Pages

  Lalitanantpong, Decha ^a   Lalitanantpong, Siriporn ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Affective; Anxiey; fMRI; Magnetic Resonance Imaging; MRI; MRS Psychiatry; Personality; Schizophrenia

Indexed keywords

ADDICTION; ANXIETY DISORDER; BRAIN FUNCTION; BRAIN METASTASIS; BRAIN SIZE; CEREBROSPINAL FLUID; CHILD PSYCHIATRY; DIAGNOSTIC IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC PREDISPOSITION; GRAY MATTER; HUMAN; MENTAL DISEASE; MOOD DISORDER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGANIC PSYCHOSYNDROME; PERSONALITY DISORDER; REVIEW; SCHIZOPHRENIA; WHITE MATTER;

ANXIETY DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MENTAL DISORDERS; MOOD DISORDERS; PERSONALITY DISORDERS;

EID: 22744437144     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Demaerel P. Magnetic resonance imaging in psychiatry. Acta Neurol Belg 2000; 100: 18-23.
2. Meisenzahl EM, Schlosser R. Functional magnetic resonance imaging research in psychiatry. Neuroimaging Clin N Am 2001; 11: 365-74.
3. Weight DG, Bigler ED. Neuroimaging in psychiatry. Psychiatr Clin North Am 1998; 21: 725-59.
4. Chung SM. Safety issues in magnetic resonance imaging. J Neuroophthalmol 2002; 22: 35-9.
5. Yurgelun-Todd DA, Renshaw PF. Applications of functional MR imaging to research in psychiatry. Neuroimaging Clin N Am 1999; 9: 295-308.
6. Hugdahl K, Rund BR, Lund A, Asbjornsen A, Egeland J, Ersland L, Landro NI, Roness A, Stordal KI, Sundet K, Thomsen T. Brain activation measured with fMRI during a mental arithmetic task in schizophrenia and major depression. Am J Psychiatry 2004; 161: 286-93.
7. Malhi GS, Valenzuela M, Wen W, Sachdev P. Magnetic resonance spectroscopy and its applications in psychiatry. Aust NZJ Psychiatry 2002; 36: 31-43.
8. O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR. 1H MRSI evidence of metabolic abnormalities in childhood-onset chizophrenia. Neuroimage 2004; 21: 1781-9.
9. Heckers S, Weiss AP, Deckersbach T, Goff DC, Morecraft RJ, Bush G. Anterior cingulate cortex activation during cognitive interference in schizophrenia. Am J Psychiatry 2004; 161: 707-15.
10. Ragland JD, Gur RC, Valdez J, Turetsky BI, Elliott M, Kohler C, Siegel S, Kanes S, Gur RE. Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia. Am J Psychiatry 2004; 161: 1004-15.
11. Kasai K, Shenton ME, Salisbury DF, Onitsuka T, Toner SK, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW. Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis. Arch Gen Psychiatry 2003; 60: 1069-77.
12. Narr KL, Bilder RM, Kim S, Thompson PM, Szeszko P, Robinson D, Luders E, Toga AW. Abnormal gyral complexity in first-episode schizophrenia. Biol Psychiatry 2004; 55: 859-67.
13. Csernansky JG, Schindler MK, Splinter NR, Wang L, Gado M, Selemon LD, Rastogi-Cruz D, Posener JA, Thompson PA, Miller MI. Abnormalities of thalamic volume and shape in schizophrenia Am J Psychiatry 2004; 161: 896-902.
14. Diwadkar VA, DeBellis MD, Sweeney JA, Pettegrew JW, Keshavan MS. Abnormalities in MRI-measured signal intensity in the corpus callosum in schizophrenia. Schizophr Res 2004; 67: 277-82.
15. Kalus P, Buri C, Slotboom J, Gralla J, Remonda L, Dierks T, Strik WK, Schroth G, Kiefer C. Volumetry and diffusion tensor imaging of hippocampal subregions in schizophrenia. Neuroreport 2004; 15: 867-71.
16. Gangadhar BN, Jayakumar PN, Subbakrishna DK, Janakiramaiah N, Keshavan MS. Basal Ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study. Am J sychiatry 2004; 161: 1304-6.
17. DeLisi LE, Sakuma M, Maurizio AM, Relja M, Hoff AL. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res 2004; 130: 57-70.
18. Keshavan MS, Diwadkar VA, Spencer SM, Harenski KA, Luna B, Sweeney JA. A preliminary functional magnetic resonance imaging study in offspring of schizophrenic parents. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 1143-9.
19. Calhoun VD, Kiehl KA, Liddle PF, Pearlson GD. Aberrant localization of synchronous hemodynamic activity in auditory cortex reliably characterizes schizophrenia. Biol Psychiatry 2004; 55: 842-9.
20. Tregellas JR, Tanabe JL, Miller DE, Ross RG, Olincy A, Freedman R. Neurobiology of smooth pursuit eye movement deficits in schizophrenia: an fMRI study, Am J Psychiatry 2004; 161: 315-21.
21. Sigmundsson T, Maier M, Toone BK, Williams SC, Simmons A, Greenwood K, Ron MA. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res 2003; 64: 63-71.
22. Delamillieure P, Constans JM, Fernandez J, Brazo P, Benali K, Courtheoux P, Thibaut F, Petit M, Dollfus S. Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex. Schizophr Bull 2002; 28: 329-39.
23. Bustillo JR, Rowland LM, Lauriello J, Petropoulos H, Hammond R, Hart B, Brooks WM. High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia. Am J Psychiatry 2002; 159: 130-3.
24. Tibbo P, Hanstock C, Valiakalayil A, Allen P. 3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia. Am J Psychiatry 2004; 161: 1116-8.
25. Jensen JE, Miller J, Williamson PC, Neufeld RW, Menon RS, Malla A, Manchanda R, Schaefer B, Densmore M, Drost DJ. Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla. Br J Psychiatry 2004; 184: 409-15.
26. Krishnan KR, Gadde KM, Kim YD. Psychoneuro-endocrinology and brain imaging in depression. Psychiatr Clin North Am 1998; 21: 465-72.
27. Tiemeier H. Biological risk factors for late life depression. Eur J Epidemiol 2003; 18: 745-50.
28. Kanner AM. Structural MRI changes of the brain in depression Clin EEG Neurosci 2004; 35: 46-52.
29. Hastings RS, Parsey RV, Oquendo MA, Arango V, Mann JJ. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 2004; 29: 952-9.
30. Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 2004; 161: 598-607.
31. Sheline YI, Mittler BL, Mintun MA. The hippocampus and depression Eur Psychiatry 2002; 17 Suppl 3: 300-5.
32. Lacerda AL, Keshavan MS, Hardan AY, Yorbik O, Brambilla P, Sassi RB, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, Scares JC. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry 2004; 55: 353-8.
33. MacMaster FP, Kusumakar V. MRI study of the pituitary gland in adolescent depression. J Psychiatr Res 2004; 38: 231-6.
34. Morys JM, Bobek-Billewicz B, Dziewiatkowski J, Ratajczak I, Pankiewicz P, Narkiewicz O, Morys J. A magnetic resonance volumetric study of the temporal lobe structures in depression. Folia Morphol (Warsz) 2003; 62: 347-52.
35. Lacerda AL, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Scares JC. Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res 2003 30; 124: 129-40.
36. Ballmaier M, Sowell ER, Thompson PM, Kumar A, Narr KL, Lavretsky H, Welcome SE, DeLuca H, Toga AW. Mapping brain size and cortical gray matter changes in elderly depression. Biol Psychiatry 2004; 55: 382-9.
37. Ehrlich S, Noam GG, Lyoo IK, Kwon BJ, Clark MA, Renshaw PF. White matter hyperintensities and their associations with suicidality in psychiatrically hospitalized children and adolescents. J Am Acad Child Adolesc Psychiatry 2004; 43: 770-6.
38. Hastings RS, Parsey RV, Oquendo MA, Arango V, Mann JJ. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 2004; 29: 952-9.
39. Yang JC. Functional neuroanatomy in depressed patients with sexual dysfunction: blood oxygenation level dependent functional MR imaging. Korean J Radiol 2004; 5: 87-95.
40. Levy RM, Steffens DC, McQuoid DR, Provenzale JM, MacFall JR, Krishnan KR. MRI lesion severity and mortality in geriatric depression. Am J Geriatr Psychiatry 2003; 11: 678-82.
41. Baldwin R, Jeffries S, Jackson A, Sutcliffe C, Thacker N, Scott M, Burns A. Treatment response in late-onset depression: relationship to neuropsychological, neuro-radiological and vascular risk factors. Psychol Med 2004; 34: 125-36.
42. Malhi GS, Lagopoulos J, Ward PB, Kumari V, Mitchell PB, Parker GB, Ivanovski B, Sachdev P. Cognitive generation of affect in bipolar depression: an fMRI study. Eur J Neurosci 2004; 19: 741-54.
43. Schwartz CE, Rauch SL. Temperament and its implications for neuroimaging of anxiety disorders. CNS Spectr 2004; 9: 284-91.
44. De Bellis MD, Keshavan MS, Shifflett H, Iyengar S, Dahl RE, Axelson DA, Birmaher B, Hall J, Moritz G, Ryan ND. Superior temporal gyrus volumes in pediatric generalized anxiety disorder. Biol Psychiatry 2002; 51: 553-62.
45. Kellner CH, Jolley RR, Holgate RC, Austin L, Lydiard RB, Laraia M, Ballenger JC. Brain MRI in obsessive-compulsive disorder. Psychiatry Res 1991; 36: 45-9.
46. Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004; 61: 564-76.
47. Uchida RR, Del-Ben CM, Santos AC, Araujo D, Crippa JA, Guimaraes FS, Graeff FG. Decreased left temporal lobe volume of panic patients measured by magnetic resonance imaging. Braz J Med Biol Res 2003; 36: 925-9.
48. Rauch SL, Shin LM, Wright CI. Neuroimaging studies of amygdala function in anxiety disorders. Ann N Y Acad Sci 2003; 985: 389-410.
49. Dilger S, Straube T, Mentzel HJ, Fitzek C, Reichenbach JR, Hecht H, Krieschel S, Gutberiet I, Miltner WH. Brain activation to phobia-related pictures in spider phobic humans: an event-related functional magnetic resonance imaging study. Neurosci Lett 2003; 348: 29-32.
50. Paquette V Levesque J, Mensour B, Leroux JM, Beaudoin G, Bourgouin P, Beauregard M. "Change the mind and you change the brain": effects of cognitive-behavioral therapy on the neural correlates of spider phobia Neuroimage 2003; 18: 401-9.
51. Driessen M, Beblo T, Mertens M, Piefke M, Rullkoetter N, Silva-Saavedra A, Reddemann L, Rau H, Markowitsch HJ, Wulff H, Lange W, Woermann FG. Posttraumatic stress disorder and fMRI activation patterns of traumatic memory in patients with borderline personality disorder. Biol Psychiatry 2004; 55: 603-11.
52. Nutt DJ, Malizia AL. Structural and functional brain changes in posttraumatic stress disorder. J Clin Psychiatry 2004; 65 Suppl 1: 11-7.
53. Reuter M, Stark R, Hennig J, Walter B, Kirsch P, Schienle A, Vaitl D. Personality and emotion: test of Gray's personality theory by means of an fMRI study. Behav Neurosci 2004; 118: 462-9.
54. Levitt JJ, Westin CF, Nestor PG, Estepar RS, Dickey CC, Voglmaier MM, Seidman LJ, Kikinis R, Jolesz FA, McCarley RW, Shenton ME. Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder. Biol Psychiatry 2004; 55: 177-84.
55. Raine A, Lencz T, Yaralian P, Bihrle S, LaCasse L, Ventura J, Colletti P. Prefrontal structural and functional deficits in schizotypal personality disorder. Schizophr Bull 2002; 28: 501-13.
56. Johnson PA, Hurley RA, Benkelfat C, Herpertz SC, Taber KH. Understanding emotion regulation in borderline personality disorder: contributions of neuroimaging. J Neuropsychiatry Clin Neurosci 2003; 15: 397-402.
57. Donegan NH, Sanislow CA, Blumberg HP, Fulbright RK, Lacadie C, Skudlarski P, Gore JC, Olson IR, McGlashan TH, Wexler BE., Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry 2003; 54: 1284-93.
58. Brower MC, Price BH. Neuropsychiatry of frontal lobe dysfunction in violent and criminal behaviour: a critical review. J Neurol Neurosurg Psychiatry 2001; 71: 720-6.
59. Kiehl KA, Smith AM, Mendrek A, Forster BB, Hare RD, Liddle PF. Temporal lobe abnormalities in semantic processing by criminal psychopaths as revealed by functional magnetic resonance imaging. Psychiatry Res 2004; 130: 27-42.
60. Jorge RE, Robinson RG, Moser D, Tateno A, Crespo-Facorro B, Arndt S. Major depression following traumatic brain injury. Arch Gen Psychiatry 2004; 61: 42-50.
61. Korf ES, Wahlund LO, Visser PJ, Scheltens P. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004; 63: 94-100.
62. Myrick H, Anton RF, Li X, Henderson S, Drobes D, Voronin K, George MS. Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology 2004; 29: 393-402.
63. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004; 24: 6028-36.
64. Cowan RL, Lyoo IK, Sung SM, Ahn KH, Kim MJ, Hwang J, Haga E, Vimal RL, Lukas SE, Renshaw PF. Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study. Drug Alcohol Depend 2003; 72: 225-35.
65. Rapoport JL, Castellanos FX, Gogate N, Janson K, Kohler S, Nelson P. Imaging normal and abnormal brain development: new perspectives for child psychiatry. Aust N Z J Psychiatry 2001; 35: 272-81.
66. Ballmaier M, Toga AW, Siddarth P, Blanton RE, Levitt JG, Lee M, Caplan R. Thought disorder and nucleus accumbens in childhood: a structural MRI study. Psychiatry Res 2004; 130: 43-55.
67. Tashiro M. Impacts of neuroimaging on psychooncology. Psychooncology 2004; 13: 486-9.